Generex Biotechnology Corporation  

(Public, OTCMKTS:GNBT)   Watch this stock  
Find more results for gnbt
4.00
0.00 (0.00%)
Aug 23 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 4.00 - 4.00
52 week 2.00 - 20.00
Open 4.00
Vol / Avg. 925.00/3,243.00
Mkt cap 4.27M
P/E     -
Div/yield     -
EPS -59.00
Shares 1.07M
Beta 0.25
Inst. own 0%

Key stats and ratios

Q2 (Apr '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -2484.07% -285.19%
Return on average equity - -
Employees 8 -
CDP Score - -

Address

10102 USA Today Way
MIRAMAR, FL 33025-3903
United States - Map
+1-416-3642551 (Phone)
+1-647-5477104 (Fax)

Description

Generex Biotechnology Corporation is a development-stage company. The Company is engaged in the research and development of drug delivery systems and technologies. The Company is involved in the development of a platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones and vaccines. The Company's subsidiary, Antigen Express, Inc. (Antigen), is engaged in research and development of technologies and immunomedicines for the treatment of malignant, infectious, autoimmune and allergic diseases. The Company holds interests in Hema Diagnostic Systems, LLC (Hema). Hema is in the business of developing, manufacturing, and distributing of in-vitro medical diagnostics for infectious diseases administered at the point of care level. Hema manufactures and sells rapid diagnostic devices based upon its own EXPRESS technology, as well as cassette devices based on customary designs used in the industry.

Officers and directors

Mark A. Fletcher Esq President, Chief Executive Officer, General Counsel, Director
Stephen Fellows Chief Financial Officer
David A Brusegard Ph.D. Chief Operating Officer, Secretary
Andrew Greene Director
Eric von Hofe Ph.D. Director
Age: 59
James H. Anderson Jr,M.D. Independent Director
Age: 68
Brian T. McGee Independent Director
Age: 53